ColoTrue (Pathway Genomics) Dallas
Approximately 25 percent of all cases of colorectal cancers can be attributed to heritable genetic changes. Understanding what genetic risk factors a patient possesses can help create personalized risk-reducing strategies and guide preventive measures.
Patient Target Criteria for Testing
- Early onset colorectal cancer
- History of adenomas under the age of 50
- Large clusters of adenomas (>10) at any age
- History of ovarian, uterine, or other cancers in first or second-degree relatives
- Modifying frequency and age of onset for targeted cancer screening
- Determining targeted risk reduction or preventive strategies
- Identifying if additional family members may be at risk
Benefits of Testing
- Modifying frequency and age of onset for targeted cancer screening
- Determining targeted risk reduction or preventive strategies
- Identifying if additional family members may be at risk
